DEALS 2,867,881

update
Fosun International is offering EUR 451M to buy Espirito Santo Saude
Buyer/Investor : Fosun International Ltd. 复星国际 , A Second exemple company Ltd. 复星国际
Target : Espirito Santo Saude 公司
Amount : 451.00 million EUR
Announced date: 15/12/03
NCPC received subsidy RMB 22.2 million from Finance Department of Henan Province
Buyer/Investor : Government 政府
Target : NCPC Semisyntech Pharmaceutical Co. Ltd. 华北制药集团先泰药业有限公司
Amount: 22.2 Million USD
Announced date: 15/12/03
China CDC (IVDC) has reached a collaborative research agreement with ContraFect Corporation for the latter's Universal Infuenza Treatment
Buyer/Investor : Chinese Center for Disease Control and Prevention 中国疾病预防控制中心
Target : XContraFect Corporation ContraFect 公司
Amount : N/A USD
Shanghai-based Jiankangbao Internet Technology has announced the launch of a cloud health plan
Buyer/Investor : Shanghai-based Jiankangbao Internet Technology Co., Ltd., 上海健康宝公司
Target : Aliyun cloud 阿里云
Amount : N/A USD
Announced date: 15/02/03
Walvax Biotechnology Co. has released a circular stating that it has signed with an individual investor
Buyer/Investor : Shanghai-based Jiankangbao Internet Technology Co., Ltd., 上海健康宝公司
Target : Aliyun cloud 阿里云
Amount : 103.3 million USD
Announced date: 15/12/01
Kunming Pharmaceutical has released a circular stating to establish a new joint venture with Hong Kong Yiyun Pharmaceutical Technology
Buyer/Investor : Kunming Pharmaceutical Co., Ltd., 昆明制药集团股份有限公司
Hong Kong Yiyun Pharmaceutical Technology Co., Ltd., 香港医韵医药技术有限公司
Target : New Co. 新公司
Amount : 163.00 million RMB
Announced date: 15/10/05
  Word   Excel

200,000 more specialities available

Subscribe to a Premium Account :
Subscribe   orLearn More

Feedback

  Request training   Submit

GBI Logo
www.gbihealth.com
Suite 301, Building 2, 169 Mengzi Rd.
Shanghai 200023, P.R. China
  (8621) 5302 2951
  (8621) 5302 2950
PRODUCTS
SERVICES
CONTACT GBI
© 2014 GB Group Limited. All Rights Reserved.    Terms of Service Privacy Policy